Next Science Limited (NXS.AX)
AUD 0.12
(0.0%)
AUD 0.12
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 11.54 Million USD | 91.37% |
| 2022 | 11.9 Million USD | 45.29% |
| 2021 | 8.19 Million AUD | 154.63% |
| 2020 | 3.21 Million AUD | 145.07% |
| 2019 | -7.13 Million AUD | 35.05% |
| 2018 | -10.99 Million AUD | -385861.87% |
| 2017 | -2847.95 AUD | 99.83% |
| 2016 | -1.68 Million AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 13.44 Million AUD | -2.66% |
| 2023 FY | 22.78 Million USD | 91.37% |
| 2023 Q2 | 9.32 Million AUD | 48.11% |
| 2023 Q4 | 13.52 Million AUD | 45.09% |
| 2022 Q2 | 5.61 Million AUD | 6.35% |
| 2022 FY | 11.9 Million USD | 45.29% |
| 2022 Q4 | 6.29 Million AUD | 12.05% |
| 2021 FY | 8.19 Million AUD | 154.63% |
| 2021 Q2 | 3.98 Million AUD | 76.07% |
| 2021 Q4 | 5.28 Million AUD | 32.43% |
| 2020 FY | 3.21 Million AUD | 145.07% |
| 2020 Q2 | -5.23 Million AUD | -31.35% |
| 2020 Q4 | 2.26 Million AUD | 143.3% |
| 2019 Q4 | -3.98 Million AUD | -25.8% |
| 2019 FY | -7.13 Million AUD | 35.05% |
| 2019 Q2 | -3.16 Million AUD | -352.73% |
| 2018 FY | -10.99 Million AUD | -385861.87% |
| 2018 Q4 | 1.25 Million AUD | 0.0% |
| 2017 FY | -2847.95 AUD | 99.83% |
| 2016 FY | -1.68 Million AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Althea Group Holdings Limited | 2.13 Million AUD | -441.576% |
| Cann Group Limited | 3.19 Million AUD | -261.39% |
| ECS Botanics Holdings Ltd | 7.51 Million AUD | -53.697% |
| Ecofibre Limited | -1.08 Million AUD | 1168.123% |
| Elixinol Wellness Limited | -1.8 Million AUD | 740.045% |
| Hygrovest Limited | 260 Thousand AUD | -4340.925% |
| IDT Australia Limited | 6.7 Million AUD | -72.283% |
| Invion Limited | 1 Million AUD | -1050.913% |
| Little Green Pharma Ltd | 11.97 Million AUD | 3.6% |
| Live Verdure Ltd | 695.99 Thousand AUD | -1558.983% |
| Medical Developments International Limited | -2.5 Million AUD | 561.856% |
| Vitura Health Limited | 34.21 Million AUD | 66.258% |
| Vita Life Sciences Limited | 42.6 Million AUD | 72.898% |